Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.93 USD | +12.90% | +11.09% | -11.26% |
05:09pm | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
05-07 | Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.26% | 1.23B | |
+33.73% | 700B | |
-4.96% | 358B | |
+18.83% | 330B | |
+3.40% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+5.59% | 161B | |
-1.99% | 157B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira BioSciences Chief Executive to Retire